Evidence map›Paper›PMID 34843015›Full record

Trial reportMolecular and cellular biochemistry2022

Determinants of high-density lipoprotein (HDL) functions beyond proteome in Asian Indians: exploring the fatty acid profile of HDL phospholipids.

Himani Thakkar, Vinnyfred Vincent, Ambuj Roy, Ajay Kumar Gautam, Rintu Kutum, Lakshmy Ramakrishnan, Sandeep Singh, Archna Singh

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Molecular and cellular biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Himani ThakkarDepartment of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Vinnyfred VincentDepartment of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Ambuj RoyDepartment of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
Ajay Kumar GautamDepartment of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Rintu KutumInformatics and Big Data Unit, Council of Scientific and Industrial Research (CSIR), Institute of Genomics and Integrative Biology (IGIB), New Delhi, India.
Lakshmy RamakrishnanDepartment of Cardiac Biochemistry, Cardiothoracic and Neurosciences Centre, All India Institute of Medical Sciences, New Delhi, India.
Sandeep SinghDepartment of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
Archna SinghDepartment of Biochemistry, All India Institute of Medical Sciences, New Delhi, India. arch_singh@ymail.com.ORCID http://orcid.org/0000-0001-6487-6632
All India Institute of Medical Sciences · INInstitute of Genomics and Integrative Biology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Impaired high-density lipoprotein (HDL) functions are associated with development of coronary artery disease. In this study, we explored the quantitative differences in HDL (i.e. HDL proteome and fatty acid profile of HDL phospholipids) underlying the functional deficits associated with acute coronary syndrome (ACS). The relationship between HDL function and composition was assessed in 65 consecutive ACS patients and 40 healthy controls. Cholesterol efflux capacity (CEC) of HDL and lecithin cholesterol acyl transferase (LCAT) activity were significantly lower in patients with ACS compared to controls. In HDL proteome analysis, HDL isolated from ACS individuals was enriched in apolipoprotein C2 (inhibitor of LCAT), apolipoprotein C4 and serum amyloid A proteins and was deficient in apolipoprotein A-I and A-II. The fatty acid profile of HDL phospholipids analyzed using gas chromatography showed significantly lower percentages of stearic acid (17.4 ± 2.4 vs 15.8 ± 2.8, p = 0.004) and omega-3 fatty acids [eicosapentaenoic acid (1.0 (0.6-1.4) vs 0.7 (0.4-1.0), p = 0.009) and docosahexaenoic acid (1.5 ± 0.7 vs 1.3 ± 0.5, p = 0.03)] in ACS patients compared to controls. Lower percentages of these fatty acids in HDL were associated with higher odds of developing ACS. Our results suggest that distinct phospholipid fatty acid profiles found in HDL from ACS patients could be one of the contributing factors to the deranged HDL functions in these patients apart from the protein content and the inflammatory conditions.

Indexed as

Acute Coronary SyndromeAdultAsian PeopleFemaleHumansIndiaLipoproteins, HDLMaleMiddle AgedPhospholipidsProteomeLipoproteins, HDLPhospholipidsProteomeAtherosclerosisFatty acidsHigh-density lipoproteinLecithin cholesterol acyl transferasePhospholipids

Identifiers

PMID34843015
OpenAlexW3215439119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.